Related Experiment Video
Updated: May 27, 2026
05:44
Formation of Dispersible Taohong Siwu Tablets
Published on: February 3, 2023
A novel off-center paddle impeller (OPI) dissolution testing system for reproducible dissolution testing of solid
Yimin Wang1, Piero M Armenante
1Otto H. York Department of Chemical, Biological and Pharmaceutical Engineering, New Jersey Institute of Technology, Newark, New Jersey 07102, USA.
Journal of Pharmaceutical Sciences
|November 16, 2011
Summary
A modified dissolution testing apparatus (OPI) improves drug release testing robustness. The off-center paddle impeller design minimizes tablet location variability, ensuring more reliable in vitro drug release data for quality control.
Area of Science:
- Pharmaceutical Science
- Drug Delivery
- Analytical Chemistry
Background:
- Dissolution testing is crucial for pharmaceutical quality control, providing in vitro drug release data.
- The standard United States Pharmacopeia (USP) Dissolution Testing Apparatus 2 is sensitive to the initial random tablet location.
- This variability can lead to artifacts and affect the reliability of dissolution profiles.
Purpose of the Study:
- To design and evaluate a modified USP Apparatus 2 to overcome tablet location sensitivity.
- To assess the impact of an off-center paddle impeller (OPI) on dissolution testing robustness.
- To compare dissolution profiles generated by the OPI system versus the standard system.
Main Methods:
- A modified Apparatus 2, termed OPI, was designed with an impeller placed 8 mm off-center.
- Dissolution tests were performed using both disintegrating (prednisone) and nondisintegrating (salicylic acid) tablets.
- Nine different tablet locations at the vessel bottom were tested for both the OPI and standard apparatus.
Main Results:
- Dissolution profiles in the OPI apparatus were largely independent of the tablet's initial location.
- The standard USP Apparatus 2 generated statistically different dissolution profiles based on tablet location.
- The OPI system demonstrated significantly reduced variability compared to the standard system.
Conclusions:
- The off-center paddle impeller (OPI) system effectively eliminates artifacts caused by random tablet settling.
- The OPI apparatus enhances the robustness and reliability of in vitro drug release testing.
- This modified system offers a more consistent approach to dissolution testing for solid dosage forms.
More Related Videos
Related Concept Videos
01:13In Vitro Drug Dissolution: Compendial Testing Models I
Compendial dissolution methods are standardized procedures defined by pharmacopeias to evaluate the rate at which a drug dissolves in a specific medium. These methods ensure batch-to-batch consistency, enable quality control, and support the prediction of drug bioavailability. They are critical for both immediate and modified-release drug products.The apparatuses used for dissolution testing differ in their design and mechanical function, but all aim to simulate the physiological environment of...
01:09In Vitro Drug Dissolution: Compendial Testing Models II
Various dissolution methods are utilized to assess a drug’s dissolution rate, including the flow-through cell, paddle-over-disk, cylinder, and reciprocating disk methods.The flow-through cell apparatus (USP (United States Pharmacopeia) method 4) comprises a reservoir for the dissolution medium and a pump that propels the medium through the cell containing the test sample. This method is crucial for assessing modified-release dosage forms with minimally soluble active ingredients, maintaining...
01:17In Vitro Drug Dissolution: Alternative Methods
Alternative drug dissolution methods include the rotating bottle, intrinsic dissolution test, peristalsis, and the Franz diffusion cell method. The rotating bottle method involves meticulously rotating tightly capped controlled-release beads in a temperature-controlled bath. Periodic decanting of samples allows for residue assay, followed by refilling with fresh medium and testing at various pH levels to emulate the gastrointestinal tract conditions.In contrast, the intrinsic dissolution test...
01:10In Vitro Drug Release Testing: Overview, Development and Validation
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
01:14Drug Dissolution: Requirements and Profile Comparison
The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...
01:23Factors Affecting Dissolution: Particle Size and Effective Surface Area
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are employed to...